Darryl S. Baker
2013
In 2013, Darryl S. Baker earned a total compensation of $1.1M as Chief Financial Officer at INSYS Therapeutics.
Compensation breakdown
| Bonus | $135,000 |
|---|---|
| Option Awards | $749,522 |
| Salary | $202,917 |
| Other | $957 |
| Total | $1,088,396 |
Baker received $749.5K in option awards, accounting for 69% of the total pay in 2013.
Baker also received $135K in bonus, $202.9K in salary and $957 in other compensation.
Rankings
In 2013, Darryl S. Baker's compensation ranked 6,226th out of 12,286 executives tracked by ExecPay. In other words, Baker earned more than 49.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,226 out of 12,286 | 49th |
Division Manufacturing | 2,176 out of 4,612 | 53rd |
Major group Chemicals And Allied Products | 647 out of 1,462 | 56th |
Industry group Drugs | 468 out of 1,156 | 60th |
Industry Pharmaceutical Preparations | 375 out of 890 | 58th |
Source: SEC filing on April 19, 2016.
Baker's colleagues
We found one more compensation record of an executive who worked with Darryl S. Baker at INSYS Therapeutics in 2013.
2013
Michael Babich
INSYS Therapeutics